Header Logo

Connection

ARNOLD DELA CRUZ PAULINO to Child

Back to Details
This is a "connection" page, showing publications ARNOLD DELA CRUZ PAULINO has written about Child.
ARNOLD DELA CRUZ PAULINO
Connection Strength
2.488
Child
  1. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.054
  2. Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma. Pediatr Blood Cancer. 2024 Jul; 71(7):e31022.
    View in: PubMed
    Score: 0.052
  3. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
    View in: PubMed
    Score: 0.052
  4. Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy. Pediatr Blood Cancer. 2023 01; 70(1):e29981.
    View in: PubMed
    Score: 0.047
  5. Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
    View in: PubMed
    Score: 0.047
  6. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):164-173.
    View in: PubMed
    Score: 0.046
  7. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021 Oct 15; 127(20):3865-3871.
    View in: PubMed
    Score: 0.043
  8. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.042
  9. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):718-725.
    View in: PubMed
    Score: 0.042
  10. Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meeting. Pediatr Blood Cancer. 2020 10; 67(10):e28619.
    View in: PubMed
    Score: 0.041
  11. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma. Pediatr Blood Cancer. 2019 08; 66(8):e27786.
    View in: PubMed
    Score: 0.037
  12. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2019 05; 134:143-150.
    View in: PubMed
    Score: 0.037
  13. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatr Blood Cancer. 2018 08; 65(8):e27095.
    View in: PubMed
    Score: 0.035
  14. Radiation pneumonitis in pediatric Hodgkin lymphoma patients receiving radiation therapy to the chest. Pract Radiat Oncol. 2018 Sep - Oct; 8(5):e364-e368.
    View in: PubMed
    Score: 0.034
  15. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
    View in: PubMed
    Score: 0.034
  16. Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.033
  17. Radiotherapy Deferral in Medulloblastoma. JAMA Oncol. 2016 Dec 01; 2(12):1582.
    View in: PubMed
    Score: 0.031
  18. Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol. 2015 Feb; 114(2):224-9.
    View in: PubMed
    Score: 0.027
  19. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):858-62.
    View in: PubMed
    Score: 0.027
  20. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):93-8.
    View in: PubMed
    Score: 0.027
  21. Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma. Pediatr Hematol Oncol. 2014 May; 31(4):366-8.
    View in: PubMed
    Score: 0.026
  22. Therapeutic challenges in treating patients with fragile X syndrome and neoplasia. Pediatr Blood Cancer. 2013 Dec; 60(12):E153-6.
    View in: PubMed
    Score: 0.025
  23. Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis. Cancer. 2013 Sep 01; 119(17):3228-33.
    View in: PubMed
    Score: 0.025
  24. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun; 36(3):283-6.
    View in: PubMed
    Score: 0.025
  25. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. Cancer. 2013 Jul 15; 119(14):2654-9.
    View in: PubMed
    Score: 0.024
  26. Rhabdomyosarcoma arising in a previously irradiated field: an analysis of 43 patients. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):598-603.
    View in: PubMed
    Score: 0.023
  27. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):350-4.
    View in: PubMed
    Score: 0.023
  28. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2012 Jun; 58(6):860-4.
    View in: PubMed
    Score: 0.022
  29. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1341-51.
    View in: PubMed
    Score: 0.021
  30. Characteristics and outcome of radiation and chemotherapy-related mucoepidermoid carcinoma of the salivary glands. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1137-41.
    View in: PubMed
    Score: 0.021
  31. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.020
  32. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2011 Feb; 56(2):279-81.
    View in: PubMed
    Score: 0.020
  33. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.020
  34. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):72-8.
    View in: PubMed
    Score: 0.020
  35. Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum. Semin Radiat Oncol. 2010 Jan; 20(1):12-20.
    View in: PubMed
    Score: 0.019
  36. Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatr Blood Cancer. 2009 Dec 15; 53(7):1332-3.
    View in: PubMed
    Score: 0.019
  37. The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):79-84.
    View in: PubMed
    Score: 0.019
  38. The carotid artery: an organ at risk and often neglected. Pediatr Blood Cancer. 2009 Oct; 53(4):529-30.
    View in: PubMed
    Score: 0.019
  39. Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol. 2009 Feb; 90(2):242-6.
    View in: PubMed
    Score: 0.018
  40. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):173-7.
    View in: PubMed
    Score: 0.017
  41. Intensity-modulated radiation therapy in childhood ependymoma. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):987-93.
    View in: PubMed
    Score: 0.017
  42. Rhabdomyosarcoma. Curr Probl Cancer. 2008 Jan-Feb; 32(1):7-34.
    View in: PubMed
    Score: 0.017
  43. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):477-83.
    View in: PubMed
    Score: 0.017
  44. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Aug; 49(2):145-8.
    View in: PubMed
    Score: 0.016
  45. An analysis of primary site control and late effects according to local control modality in non-metastatic Ewing sarcoma. Pediatr Blood Cancer. 2007 Apr; 48(4):423-9.
    View in: PubMed
    Score: 0.016
  46. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer. 2006 Jun; 46(7):739-44.
    View in: PubMed
    Score: 0.015
  47. Collins' law revisited: can we reliably predict the time to recurrence in common pediatric tumors? Pediatr Hematol Oncol. 2006 Jan-Feb; 23(1):81-6.
    View in: PubMed
    Score: 0.015
  48. Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):865-9.
    View in: PubMed
    Score: 0.014
  49. Secondary neoplasms after radiotherapy for a childhood solid tumor. Pediatr Hematol Oncol. 2005 Mar; 22(2):89-101.
    View in: PubMed
    Score: 0.014
  50. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma. Pediatr Blood Cancer. 2004 Oct; 43(5):587-93.
    View in: PubMed
    Score: 0.013
  51. Late effects of radiotherapy for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):265-74.
    View in: PubMed
    Score: 0.013
  52. Evolution of Proton Radiation Therapy Brainstem Constraints on the Pediatric Proton/Photon Consortium Registry. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e507-e514.
    View in: PubMed
    Score: 0.013
  53. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatr Blood Cancer. 2024 Jul; 71(7):e30981.
    View in: PubMed
    Score: 0.013
  54. Treatment options for children with nonrhabdomyosarcoma soft tissue sarcoma. Expert Rev Anticancer Ther. 2004 Apr; 4(2):247-56.
    View in: PubMed
    Score: 0.013
  55. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol. 2004 Apr; 27(2):122-7.
    View in: PubMed
    Score: 0.013
  56. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1171-6.
    View in: PubMed
    Score: 0.013
  57. Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2. Cancer. 2024 Jul 01; 130(13):2361-2371.
    View in: PubMed
    Score: 0.013
  58. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):655-668.
    View in: PubMed
    Score: 0.013
  59. Biodevelopmental Considerations in Pediatric Patients With Cancer and Childhood Cancer Survivors: A PENTEC Introductory Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):354-359.
    View in: PubMed
    Score: 0.013
  60. Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children's Oncology Group Studies AREN03B2 and AREN0532. Cancer. 2024 03 01; 130(5):792-802.
    View in: PubMed
    Score: 0.013
  61. Brain metastasis in children with sarcoma, neuroblastoma, and Wilms' tumor. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):177-83.
    View in: PubMed
    Score: 0.013
  62. The role of surgery in recurrent ependymomas. J Neurosurg Pediatr. 2023 11 01; 32(5):584-589.
    View in: PubMed
    Score: 0.013
  63. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003 Aug; 41(2):118-22.
    View in: PubMed
    Score: 0.012
  64. Children's Oncology Group's 2023 blueprint for research: Radiation oncology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30593.
    View in: PubMed
    Score: 0.012
  65. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
    View in: PubMed
    Score: 0.012
  66. Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1174-1180.
    View in: PubMed
    Score: 0.012
  67. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy. Med Pediatr Oncol. 2003 Jun; 40(6):396-7.
    View in: PubMed
    Score: 0.012
  68. Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR). J Neurooncol. 2023 Apr; 162(2):353-362.
    View in: PubMed
    Score: 0.012
  69. Resection cavity auto-contouring for patients with pediatric medulloblastoma using only CT information. J Appl Clin Med Phys. 2023 Jul; 24(7):e13956.
    View in: PubMed
    Score: 0.012
  70. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol. 2003 Mar; 20(2):111-7.
    View in: PubMed
    Score: 0.012
  71. Impact of Age on Overall Survival Among Children With Wilms Tumor: A Population-based Registry Analysis. Am J Clin Oncol. 2023 05 01; 46(5):213-218.
    View in: PubMed
    Score: 0.012
  72. Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only. J Neurosurg Pediatr. 2023 05 01; 31(5):453-462.
    View in: PubMed
    Score: 0.012
  73. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003 Feb; 26(1):55-9.
    View in: PubMed
    Score: 0.012
  74. Automating the treatment planning process for 3D-conformal pediatric craniospinal irradiation therapy. Pediatr Blood Cancer. 2023 03; 70(3):e30164.
    View in: PubMed
    Score: 0.012
  75. Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023 Feb; 37(2):204-217.
    View in: PubMed
    Score: 0.012
  76. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatr Blood Cancer. 2023 05; 70 Suppl 2:e30090.
    View in: PubMed
    Score: 0.012
  77. Current multimodality management of medulloblastoma. Curr Probl Cancer. 2002 Nov-Dec; 26(6):317-56.
    View in: PubMed
    Score: 0.012
  78. A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child. Pediatr Blood Cancer. 2023 03; 70(3):e29972.
    View in: PubMed
    Score: 0.012
  79. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol. 2022 11; 176:118-126.
    View in: PubMed
    Score: 0.012
  80. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):543-7.
    View in: PubMed
    Score: 0.012
  81. Predicting neurocognitive function in pediatric brain tumor early survivorship: The neurological predictor scale and the incremental validity of tumor size. Pediatr Blood Cancer. 2022 09; 69(9):e29803.
    View in: PubMed
    Score: 0.012
  82. ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534. Ann Surg Oncol. 2022 05; 29(5):3262-3263.
    View in: PubMed
    Score: 0.011
  83. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534). Cancer. 2022 07 01; 128(13):2493-2503.
    View in: PubMed
    Score: 0.011
  84. Intracranial ependymomas: an analysis of prognostic factors and patterns of failure. Am J Clin Oncol. 2002 Apr; 25(2):117-22.
    View in: PubMed
    Score: 0.011
  85. Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy. Pediatr Blood Cancer. 2022 06; 69(6):e29645.
    View in: PubMed
    Score: 0.011
  86. Intensity-modulated radiation therapy in the treatment of children. Med Dosim. 2002; 27(2):115-20.
    View in: PubMed
    Score: 0.011
  87. Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium Registry. Pract Radiat Oncol. 2022 Mar-Apr; 12(2):155-162.
    View in: PubMed
    Score: 0.011
  88. Variation in Proton Craniospinal Irradiation Practice Patterns in the United States: A Pediatric Proton Consortium Registry (PPCR) Study. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):901-912.
    View in: PubMed
    Score: 0.011
  89. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma. J Neurooncol. 2021 Oct; 155(1):93-100.
    View in: PubMed
    Score: 0.011
  90. Relapsed Wilms tumor: is there a role for radiation therapy? Am J Clin Oncol. 2001 Aug; 24(4):408-13.
    View in: PubMed
    Score: 0.011
  91. Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling. JCO Precis Oncol. 2021; 5.
    View in: PubMed
    Score: 0.011
  92. Ependymoma Presenting as a -Rim-Enhancing Lesion in the Brainstem. Pediatr Neurosurg. 2021; 56(5):455-459.
    View in: PubMed
    Score: 0.011
  93. Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma. Pediatr Blood Cancer. 2021 10; 68(10):e29178.
    View in: PubMed
    Score: 0.011
  94. Long-term cognitive and academic outcomes among pediatric brain tumor survivors treated with proton versus photon radiotherapy. Pediatr Blood Cancer. 2021 09; 68(9):e29125.
    View in: PubMed
    Score: 0.011
  95. Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):467-481.
    View in: PubMed
    Score: 0.011
  96. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
    View in: PubMed
    Score: 0.011
  97. Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer. 2021 07 01; 127(13):2358-2367.
    View in: PubMed
    Score: 0.011
  98. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1496-1504.
    View in: PubMed
    Score: 0.011
  99. The local field in infratentorial ependymoma: does the entire posterior fossa need to be treated? Int J Radiat Oncol Biol Phys. 2001 Mar 01; 49(3):757-61.
    View in: PubMed
    Score: 0.011
  100. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.
    View in: PubMed
    Score: 0.010
  101. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst. 2021 05; 37(5):1563-1572.
    View in: PubMed
    Score: 0.010
  102. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1489-95.
    View in: PubMed
    Score: 0.010
  103. Radiotherapy and Late Effects. Pediatr Clin North Am. 2020 12; 67(6):1051-1067.
    View in: PubMed
    Score: 0.010
  104. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. 2020 12; 153:163-171.
    View in: PubMed
    Score: 0.010
  105. Comparison of posterior fossa and tumor bed boost in medulloblastoma. Am J Clin Oncol. 2000 Oct; 23(5):487-90.
    View in: PubMed
    Score: 0.010
  106. Wilms tumor. Pediatr Blood Cancer. 2021 05; 68 Suppl 2:e28257.
    View in: PubMed
    Score: 0.010
  107. Early evidence of pulmonary dysfunction in survivors of childhood Hodgkin lymphoma. Leuk Lymphoma. 2020 10; 61(10):2419-2427.
    View in: PubMed
    Score: 0.010
  108. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Neuro Oncol. 2020 06 09; 22(6):875-885.
    View in: PubMed
    Score: 0.010
  109. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):585-9.
    View in: PubMed
    Score: 0.010
  110. Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group. Cancer. 2020 08 01; 126(15):3516-3525.
    View in: PubMed
    Score: 0.010
  111. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020 08; 67(8):e28373.
    View in: PubMed
    Score: 0.010
  112. Reply to S.A. Milgrom et al. J Clin Oncol. 2020 07 01; 38(19):2212-2213.
    View in: PubMed
    Score: 0.010
  113. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma. Pediatr Blood Cancer. 2020 06; 67(6):e28283.
    View in: PubMed
    Score: 0.010
  114. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381.
    View in: PubMed
    Score: 0.010
  115. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys. 2000 Mar 15; 46(5):1239-46.
    View in: PubMed
    Score: 0.010
  116. Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 Study. J Clin Oncol. 2020 05 10; 38(14):1558-1568.
    View in: PubMed
    Score: 0.010
  117. Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Jan 15; 46(2):281-6.
    View in: PubMed
    Score: 0.010
  118. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020 Jan; 146(1):147-156.
    View in: PubMed
    Score: 0.010
  119. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.010
  120. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020 02; 67(2):e28064.
    View in: PubMed
    Score: 0.010
  121. Malignant neoplasms after treatment for metachronous bilateral Wilms' tumor: a literature review. Pediatr Hematol Oncol. 1999 Nov-Dec; 16(6):533-8.
    View in: PubMed
    Score: 0.010
  122. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar; 93(1107):20190673.
    View in: PubMed
    Score: 0.010
  123. Re: Conservative surgical management of bilateral Wilms tumor: results of the United Kingdom Children's Cancer Study Group. J Urol. 1999 Jul; 162(1):167.
    View in: PubMed
    Score: 0.009
  124. Trilateral retinoblastoma: is the location of the intracranial tumor important? Cancer. 1999 Jul 01; 86(1):135-41.
    View in: PubMed
    Score: 0.009
  125. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer. 1999 Jul 01; 86(1):142-8.
    View in: PubMed
    Score: 0.009
  126. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
    View in: PubMed
    Score: 0.009
  127. Diffuse malignant leptomeningeal gliomatosis in a child: a case report and review of the literature. Am J Clin Oncol. 1999 Jun; 22(3):243-6.
    View in: PubMed
    Score: 0.009
  128. Adaptive functioning in pediatric brain tumor survivors: An examination of ethnicity and socioeconomic status. Pediatr Blood Cancer. 2019 09; 66(9):e27800.
    View in: PubMed
    Score: 0.009
  129. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol. 2019 05 06; 21(5):686-695.
    View in: PubMed
    Score: 0.009
  130. Controversies in the management of intracranial germinomas. Oncology (Williston Park). 1999 Apr; 13(4):513-21; discussion 521-2, 528-3.
    View in: PubMed
    Score: 0.009
  131. A Phase 1/2 Trial of Reirradiation for Diffuse Intrinsic Pontine Glioma. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):144-148.
    View in: PubMed
    Score: 0.009
  132. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.009
  133. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 2019 03; 132:155-161.
    View in: PubMed
    Score: 0.009
  134. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.009
  135. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 06 01; 36(16):1564-1570.
    View in: PubMed
    Score: 0.009
  136. The Children's Oncology Group Radiation Oncology Discipline: 15?Years of Contributions to the Treatment of Childhood Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):860-874.
    View in: PubMed
    Score: 0.009
  137. Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):453-461.
    View in: PubMed
    Score: 0.009
  138. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):169-176.
    View in: PubMed
    Score: 0.008
  139. Metachronous bilateral Wilms' tumor: the importance of time interval to the development of a second tumor. Cancer. 1998 Jan 15; 82(2):415-20.
    View in: PubMed
    Score: 0.008
  140. Pediatric head and neck squamous cell carcinoma: Patient demographics, treatment trends and outcomes. Int J Pediatr Otorhinolaryngol. 2018 Mar; 106:21-25.
    View in: PubMed
    Score: 0.008
  141. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532. J Clin Oncol. 2018 01 20; 36(3):254-261.
    View in: PubMed
    Score: 0.008
  142. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Pediatr Blood Cancer. 2018 Feb; 65(2).
    View in: PubMed
    Score: 0.008
  143. Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group. Ann Surg. 2017 09; 266(3):470-478.
    View in: PubMed
    Score: 0.008
  144. Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy. Radiother Oncol. 2017 07; 124(1):89-97.
    View in: PubMed
    Score: 0.008
  145. Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy. Cancer. 2017 Jul 01; 123(13):2570-2578.
    View in: PubMed
    Score: 0.008
  146. Current issues in the diagnosis and management of Wilms' tumor. Oncology (Williston Park). 1996 Oct; 10(10):1553-65; discussion 1565-71.
    View in: PubMed
    Score: 0.008
  147. Local control in synchronous bilateral Wilms tumor. Int J Radiat Oncol Biol Phys. 1996 Oct 01; 36(3):541-8.
    View in: PubMed
    Score: 0.008
  148. Paediatric radiation oncology in the care of childhood cancer: A position paper by the International Paediatric Radiation Oncology Society (PROS). Radiother Oncol. 2016 05; 119(2):357-60.
    View in: PubMed
    Score: 0.008
  149. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.007
  150. Mucoepidermoid Carcinoma in Children: A Single Institutional Experience. Pediatr Blood Cancer. 2016 Jan; 63(1):27-31.
    View in: PubMed
    Score: 0.007
  151. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):54-63.
    View in: PubMed
    Score: 0.007
  152. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):349-57.
    View in: PubMed
    Score: 0.007
  153. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):354-61.
    View in: PubMed
    Score: 0.007
  154. Long-term outcome of centrally located low-grade glioma in children. Cancer. 2013 Jul 15; 119(14):2630-8.
    View in: PubMed
    Score: 0.006
  155. Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. Neuro Oncol. 2013 Jun; 15(6):759-66.
    View in: PubMed
    Score: 0.006
  156. A Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumor. Cancer. 2012 May 01; 118(9):2541-51.
    View in: PubMed
    Score: 0.005
  157. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.004
  158. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites. Technol Cancer Res Treat. 2007 Aug; 6(4):347-54.
    View in: PubMed
    Score: 0.004
  159. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol. 2007 Jul; 29(7):500-5.
    View in: PubMed
    Score: 0.004
  160. Scheduling for radiotherapy simulation in children with a renal mass. Pediatr Hematol Oncol. 2006 Apr-May; 23(3):275-6.
    View in: PubMed
    Score: 0.004
  161. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1169-74.
    View in: PubMed
    Score: 0.004
  162. Extra-target doses in children receiving multileaf collimator (MLC) based intensity modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2004 Jun; 42(7):626-30.
    View in: PubMed
    Score: 0.003
  163. The effect of an extended source-to-skin distance in the treatment of the spinal field in children receiving craniospinal irradiation. Med Dosim. 2004; 29(1):7-10.
    View in: PubMed
    Score: 0.003
  164. Prognostic factors in head and neck rhabdomyosarcoma. Head Neck. 2002 May; 24(5):468-73.
    View in: PubMed
    Score: 0.003
  165. Determination of the inferior border of the thecal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):621-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.